CN Patent

CN113577022B — 一种氨苯砜类化合物混悬液及其制备方法和应用

Assigned to Nanjing Xintong Ruiyi Medicine Science & Technology Co ltd · Expires 2023-03-17 · 3y expired

What this patent protects

本发明公开了一种氨苯砜类化合物混悬液及其制备方法和应用，所述混悬液包含氨苯砜类化合物和高分子，所述高分子选自下列一种或多种：聚乙烯吡咯烷酮、羟丙基甲基纤维素、羟乙基纤维素、PVP/VA、Soluplus、聚乙二醇。与现有技术相比，本发明混悬液具有载药量大、粒径分布窄、稳定性好、易于生产制备和产业化应用性等优点。

USPTO Abstract

本发明公开了一种氨苯砜类化合物混悬液及其制备方法和应用，所述混悬液包含氨苯砜类化合物和高分子，所述高分子选自下列一种或多种：聚乙烯吡咯烷酮、羟丙基甲基纤维素、羟乙基纤维素、PVP/VA、Soluplus、聚乙二醇。与现有技术相比，本发明混悬液具有载药量大、粒径分布窄、稳定性好、易于生产制备和产业化应用性等优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN113577022B
Jurisdiction
CN
Classification
—
Expires
2023-03-17
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Xintong Ruiyi Medicine Science & Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.